A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai(Hammersmith Hospital), Gavin Screaton(University of Oxford), Thaneeya Duangchinda(National Science and Technology Development Agency), Wiyada Wongwiwat(Hammersmith Hospital), Alexander Rouvinski(Hebrew University of Jerusalem), Prida Malasit(National Science and Technology Development Agency), Xinghong Dai(Case Western Reserve University), F.A. Rey(Institut National de la Recherche Agronomique), Sunpetchuda Supasa(Siriraj Hospital), Cameron P. Simmons(Oxford University Clinical Research Unit), Juthathip Mongkolsapaya(Siriraj Hospital), Jonathan M. Grimes(University of Oxford), Nguyen Than Ha Quyen(Oxford University Clinical Research Unit), Amonrat Jumnainsong(Khon Kaen University), Jeremy Farrar(World Health Organization), Wei‐Kung Wang(National Taiwan University Hospital), Xiaokang Zhang(Centre National de la Recherche Scientifique), Chih-Yun Lai(University of Hawaiʻi at Mānoa), Wen-Yang Tsai(University of Hawaiʻi at Mānoa), Carolyn Edwards(Hammersmith Hospital), Zehua Zhou(California NanoSystems Institute)
Cited by 497
Related Papers
The global distribution and burden of dengue
|Nature|2013|10.1k
Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
Into the Eye of the Cytokine Storm
|Microbiology and Molecular Biology Reviews|2012|2k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Dengue
|New England Journal of Medicine|2012|1.7k